Number of HVAD™ and MVAD patients on support worldwide

1,599 HVAD™ & MVAD Patients on Support Worldwide as of Q1FY25
Source: HVAD™ site reported data, Q1FY25. Not independently confirmed or validated by Medtronic.

 

Number of years on support for ongoing HVAD supported patients†

† Data as reported by U.S. sites through November 6, 2024 (n = 626).

Kaplan-Meier estimate for overall survival1 in a contemporary HVAD™ system cohort2 per the quarterly STS intermacs report3

Underlying data provided with the permission of The Society of Thoracic Surgeons.
Copyright © 2024 The Society of Thoracic Surgeons.

  1. Subjects were censored at the time of any non-death related explant.
  2. Contemporary cohort was stratified by year-of-implant following FDA approval of the HVAD™ System for Destination Therapy (October 2017) through cessation of the sale and distribution of the device (June 2021): October-December 2017, 2018, 2019, 2020, January–June 2021.
  3. STS Intermacs Report – North American registry data of FDA-approved durable devices implanted for treatment of advanced heart failure; current analysis is for second quarter 2024 with follow-up through 30 June 2024.

STS – Society of Thoracic Surgeons; Intermacs – Interagency Registry of Mechanically Assisted Circulatory Support; FDA – Food and Drug Administration.